[LGND] QoQ Quarter Result on 31-Dec-2016 [#Q4]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
28-Feb-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- -585.25%
YoY- -149.28%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Revenue 33,375 27,995 29,267 38,185 21,619 19,521 29,648 8.20%
PBT 12,071 8,300 6,193 7,230 804 -9,644 9,571 16.71%
Tax 3,645 2,242 1,114 10,355 160 -3,881 3,694 -0.88%
NP 8,426 6,058 5,079 -3,125 644 -5,763 6,608 17.57%
Tax Rate -30.20% -27.01% -17.99% -143.22% -19.90% - -38.60% -
Total Cost 24,949 21,937 24,188 41,310 20,975 25,284 23,040 5.44%
Ratio Analysis
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
NP Margin 25.25 21.64 17.35 -8.18 2.98 -29.52 22.29 8.65%
Per Share
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
EPS 0.40 0.29 0.24 -0.15 0.03 -0.28 0.32 16.02%
EPS Diluted 0.36 0.26 0.22 -0.15 0.03 -0.28 0.30 12.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.